|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/4545 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 3/00 | (2006.01) |
| (11) | Patento numeris | 3782624 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20200033.7 |
| Europos patento paraiškos padavimo data | 2017-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-02-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-09-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| PA201670281 | 2016-04-29 | DK |
| (72) |
HINSBY, Anders Mørkeberg , DK
JENSEN, Thomas Kirkegaard , DK
Fog-Tonnesen, Cathrine Kolster , DK
PETERSEN, Nikolaj, Havnsøe, Torp , DK
Bornæs, Claus , DK
|
| (73) |
Zevra Denmark A/S ,
Nordre Fasanvej 215, 2000 Frederiksberg,
DK
|
| (54) | ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS |
| ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS |